Casein Kinase
Casein Kinases (CKs), a group of ubiquitous Ser/Thr kinases, regulate a wide range of cellular functions in eukaryotes, including phosphorylation of proteins that are substrates for degradation via the ubiquitin-proteasome system (UPS). Two casein kinases, casein kinase-1 (CK-1) and casein kinase-2 (CK-2), have been characterized from many sources.
CK1 kinases exist in at least seven isoforms (α, β, γ1-3, δ, and ɛ) in mammals and CK1 kinases phosphorylate various substrates to play vital roles in diverse physiological processes such as DNA repair, cell cycle progression, cytokinesis, differentiation, and apoptosis. Casein kinase 2 (CK2) is a highly pleiotropic serine-threonine kinase, which catalyzed phosphorylation of more than 300 proteins that are implicated in regulation of many cellular functions, such as signal transduction, transcriptional control, apoptosis, and the cell cycle.
Casein Kinase Isoform Specific Products
All Product Categories
-
Casein Kinase Inhibitors
(201)
View all products
-
Casein Kinase Antagonists
(2)
View all products
-
Casein Kinase Activator
(1)
View all products
-
Casein Kinase Chemical
(1)
View all products
-
Casein Kinase Degraders
(23)
View all products
-
Casein Kinase Substrate
(1)
View all products
-
Casein Kinase Ligand
(1)
View all products
-
Casein Kinase Related Products (247)
Related Products (247)
-
Antibodies (5)
-
Casein Kinase Isoform Comparison
-
Casein kinase 1δ-IN-7
0 ImagesCat. No.: HY-156662CAS No.: 764694-25-9Casein kinase 1δ-IN-7 (compound 497) is a Casein kinase 1δ inhibitor. Casein kinase 1δ-IN-7 can be used in the study of neurodegenerative disorders such as Alzheimer's disease.
-
BMS-159
0 ImagesCat. No.: HY-180987CAS No.: 1541248-45-6
-
Kirenol (Standard)
0 ImagesKirenol (Standard) is the analytical standard of Kirenol (HY-N0559). This product is intended for research and analytical applications. Kirenol is a diterpenoid compound, an orally active apoptosis inducer and signaling pathway regulator, with a Kd value of 5.47 μM against the target CK2. Kirenol promotes the cleavage of Bid into tBid, regulates the protein levels/phosphorylation of Bax, Bcl-2, p53 and p21, and induces caspase-independent apoptosis, S-phase cell cycle arrest, ROS accumulation and cytotoxicity in cancer cells. Kirenol activates the CK2/AKT and AMPK-mTOR-ULK1 pathways, inhibits the signaling of NF-κB, TGF-β/Smads and NLRP3 inflammasome, and regulates the GSK3β, BMP and Wnt/β-catenin pathways. Kirenol induces autophagy, mitophagy and osteoblast differentiation, promotes mitochondrial fusion, and exerts antioxidant, anti-inflammatory, antifibrotic, renoprotective, cardioprotective, neuroprotective and analgesic effects. Kirenol is applicable to research related to chronic myeloid leukemia, ischemic stroke, diabetic nephropathy, heart failure, acute lung injury and osteoporosis.
-
Casein kinase 1δ-IN-24
0 ImagesCat. No.: HY-169705CAS No.: 326034-30-4Casein kinase 1δ-IN-24 (compound 489) is a potent casein kinase 1δ inhibitor. Casein kinase 1δ-IN-24 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
-
FP1-24
0 ImagesCat. No.: HY-181585CAS No.: 1403557-08-3FP1-24 is a non-selective CK1 kinase inhibitor, with IC50 values of 40 nM, 10 nM, 10 nM, and 40 nM against human CK1γ1, CK1γ2, CK1γ3 and CK1δ, respectively. FP1-24 exerts its activity by reducing the phosphorylation level of LRP5/6 at the T1479 site during WNT signaling pathway activation. The non-specific binding of FP1-24 to multiple kinases can be used for biological studies of specific CK1γ.
-
Casein kinase 1δ-IN-10
0 ImagesCat. No.: HY-156040CAS No.: 332074-85-8Casein kinase 1δ-IN-10 is a casein kinase 1δ (CK1δ) inhibitor (WO2012080729A2; compound 685).
-
TID43
0 ImagesCat. No.: HY-120267CAS No.: 19231-60-8TID43 is a CK2 inhibitor, with an IC50 of 0.3 μM. TID43 can be used for anti-angiogenic research.
-
Pomalidomide-β-D-glucose
0 ImagesCat. No.: HY-189288CAS No.: 2894135-13-6Pomalidomide-β-D-glucose is an orally active Molecular glue degrader of IKZF1 and CK1α. Pomalidomide-β-D-glucose forms a ternary complex with CRBN and substrate proteins, inducing ubiquitination and proteasomal degradation of IKZF1 and CK1α. Pomalidomide-β-D-glucose undergoes GLUT1-mediated cellular uptake. Pomalidomide-β-D-glucose can be used for research on multiple myeloma.
-
CK2-IN-11
0 ImagesCat. No.: HY-158370CAS No.: 2938991-22-9
-
IBA-11
0 ImagesCat. No.: HY-182800IBA-11 is a selective CRBN-dependented CK1α molecular glue degrader. IBA-11 binds to the canonical tri-tryptophan pocket of CRBN, forming a ternary complex with CK1α to mediate its degradation. IBA-11 induces CRBN-dependent ubiquitin-proteasome system-mediated degradation of CK1α. IBA-11 exhibits cytotoxicity against cancer cells. IBA-11 demonstrates in vitro metabolic stability in rat liver microsomes and minimal hERG inhibition. IBA-11 can be used for the research of cancer, such as acute myeloid leukemia.
-
AH081
0 ImagesCat. No.: HY-170859A
-
CK2/PIM1-IN-1
0 ImagesCat. No.: HY-135816CAS No.: 292640-28-9CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders.
-
CK1-IN-4
0 ImagesCat. No.: HY-162756CK1-IN-4 (Compound 59) is an inhibitor for casein kinase CK1δ with IC50 of 2.74 μM. CK1-IN-4 exhibits neuroprotective effect in Ethacrynic acid (HY-B1640)-treated SH-SY5Y cells.
-
CK2-IN-17
0 ImagesCat. No.: HY-184823CAS No.: 1417634-25-3CK2-IN-17 is a protein kinase CK2 inhibitor with an IC50 of 9.5 μM against human targets. CK2-IN-17 regulates the activity of protein kinase CK2 by interacting with its ATP-binding site. CK2-IN-17 can be used in studies related to protein kinase CK2-mediated pathways, such as tumors.
-
Casein kinase 1δ-IN-14
0 ImagesCat. No.: HY-49459CAS No.: 793722-88-0Casein kinase 1δ-IN-14 (compound 481) is a casein kinase inhibitor that can be used to study neurodegenerative diseases such as Alzheimer's disease.
-
Casein kinase 1δ-IN-16
0 ImagesCat. No.: HY-169573CAS No.: 851467-69-1Casein kinase 1δ-IN-16 (compound 506) is a casein kinase 1δ (CK1δ) inhibitor. Casein kinase 1δ-IN-16 can be utilized in neurodegenerative disorders research.
